GTC Biotherapeutics (fka GTCB)

[oldacct]

Obviously what is bothering many of us is there appears
to be no business plan on preserving what little capital
is left. Green keeps repeating that we are budgeted to
lose an additional 20 million this year, but we only have
11 million. Does he know something we don't or are they
intentionally driving us into BK.

What Genzyme did to Genzyme Biosurgery is fresh in my mind.
It was the only class action suit that I gladly participated
in.

Let's hope that Cox has something up his sleeve.